Sara Redondo

6PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPharmaceutical delivery technologiesRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 23, 2025
Standard Versus Reduced-Doses of Post-Transplant Cyclophosphamide in HLA Matched (10/10) Peripheral Blood Stem Cell Transplantation.

Sara Redondo, Irene García-Cadenas, Albert Esquirol

|Dec 11, 2024
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC.

Virginia Escamilla-Gómez, Valentín García Gutiérrez, Patricia Alcalde-Mellado

|Nov 15, 2024
Development and Clinical Validation of Liquid Chromatography-Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A First Step Towards Optimized Treatment.

Sara Redondo, María Costa, Maria-Estela Moreno-Martinez

|Aug 19, 2024
Severity and organ distribution of graft-versus-host disease with post-transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA-matched or single-allele mismatched stem cell transplantation.

Sara Redondo, Irene García-Cadenas, Albert Esquirol

|Jul 15, 2023
Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center.

Miguel Arguello-Tomas, Nil Albiol, Paola Jara

|Apr 14, 2023
Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI.

Sara Redondo, Irene García-Cadenas, Antonio Vila

Pageof 1

Frequent Collaborators

4 joint publications

Irene García-Cadenas

3 joint publications

Albert Esquirol

2 joint publications

Silvana Novelli

1 joint publications

Miguel Arguello-Tomas